These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 56401)

  • 1. Response to antigenic determinants of Neisseria meningitidis lipopolysaccharide investigated with a new radioactive antigen-binding assay.
    Bertram MA; Griffiss JM; Broud DD
    J Immunol; 1976 Mar; 116(3):842-6. PubMed ID: 56401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A radioactive antigen-binding assay for Neisseria meningitidis polysaccharide antibody.
    Brandt BL; Wyle FA; Artenstein MS
    J Immunol; 1972 Apr; 108(4):913-20. PubMed ID: 4623401
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipopolysaccharide-derived serotype polysaccharides from Neisseria meningitidis group B.
    Apicella MA
    J Infect Dis; 1979 Jul; 140(1):62-72. PubMed ID: 88491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. II. Specificity.
    Rubinstein LJ; Stein KE
    J Immunol; 1988 Dec; 141(12):4357-62. PubMed ID: 3143763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity chromatography for purification of antibodies to Neisseria gonorrhoeae and Neisseria meningitidis lipopolysaccharides.
    Rødahl E; Maeland JA
    Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):247-54. PubMed ID: 6440412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia.
    Plested JS; Harris SL; Wright JC; Coull PA; Makepeace K; Gidney MA; Brisson JR; Richards JC; Granoff DM; Moxon ER
    J Infect Dis; 2003 Apr; 187(8):1223-34. PubMed ID: 12696001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).
    Coughlin RT; Bogard WC
    J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants.
    Mandrell RE; Zollinger WD
    J Immunol; 1982 Nov; 129(5):2172-8. PubMed ID: 6811660
    [No Abstract]   [Full Text] [Related]  

  • 9. A strong, specific response of mice to serotype-specific antigenic determinants of Neisseria meningitidis, analyzed with mouse monoclonal antibodies.
    Mackie EB; Mosmann TR; Bryan LE; Longenecker BM
    J Immunol; 1981 Jul; 127(1):387-8. PubMed ID: 6165772
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibody analysis of lipopolysaccharide from Neisseria gonorrhoeae and Neisseria meningitidis.
    Apicella MA; Bennett KM; Hermerath CA; Roberts DE
    Infect Immun; 1981 Dec; 34(3):751-6. PubMed ID: 6174450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidis.
    Jennings HJ; Roy R; Michon F
    J Immunol; 1985 Apr; 134(4):2651-7. PubMed ID: 2579148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits.
    Cox AD; Zou W; Gidney MA; Lacelle S; Plested JS; Makepeace K; Wright JC; Coull PA; Moxon ER; Richards JC
    Vaccine; 2005 Oct; 23(43):5045-54. PubMed ID: 16046037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic potential of a highly conserved Neisseria meningitidis lipopolysaccharide inner core structure defined by chemical synthesis.
    Reinhardt A; Yang Y; Claus H; Pereira CL; Cox AD; Vogel U; Anish C; Seeberger PH
    Chem Biol; 2015 Jan; 22(1):38-49. PubMed ID: 25601073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical contribution of both CD28 and ICOS in the adjuvant activity of Neisseria meningitidis H44/76 LPS and lpxL1 LPS.
    van Berkel ME; Schrijver EH; van Mourik A; Tesselaar K; van der Ley P; Steeghs L; Oosterwegel MA
    Vaccine; 2007 Jun; 25(24):4681-8. PubMed ID: 17499399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding to CD14.
    Kocabas C; Katsenelson N; Kanswal S; Kennedy MN; Cui X; Blake MS; Segal DM; Akkoyunlu M
    Cell Microbiol; 2007 May; 9(5):1297-310. PubMed ID: 17250593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide heterogeneity and escape mechanisms of Neisseria meningitidis: possible consequences for vaccine development.
    Rune Andersen S; Kolberg J; Høiby EA; Namork E; Caugant DA; Oddvar Frøholm L; Jantzen E; Bjune G
    Microb Pathog; 1997 Sep; 23(3):139-55. PubMed ID: 9281472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyclonal B-cell activation by Neisseria meningitidis capsular polysaccharides elicit antibodies protective against Trypanosoma cruzi infection in vitro.
    Oliveira TG; Milani SR; Travassos LR
    J Clin Lab Anal; 1996; 10(4):220-8. PubMed ID: 8811466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of rough-type lipopolysaccharides of Neisseria meningitidis from cells and outer membrane vesicles in spent media.
    Gu XX; Tsai CM
    Anal Biochem; 1991 Aug; 196(2):311-8. PubMed ID: 1776680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface polysaccharide of Moraxella non-liquefaciens identical to Neisseria meningitidis group B capsular polysaccharide. A chemical and immunological investigation.
    Bøvre K; Bryn K; Closs O; Hagen N; Frøholm LO
    NIPH Ann; 1983 Jun; 6(1):65-73. PubMed ID: 6413906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine.
    Donnelly JJ; Deck RR; Liu MA
    J Immunol; 1990 Nov; 145(9):3071-9. PubMed ID: 2120344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.